Tutkijat / Kuopio  | Airaksinen, O(lavi) |
| Alhava, E. |
| Alhonen, L. |
| Atalay, M(ustafa) |
| Cederberg, H. |
| Dunkel, L(eo) |
| Eskelinen, M(atti) |
| Giniatullin, R. |
| Gröhn, O(lli) |
| Harno, K. |
| Hartikainen, J(aana). |
| Hartikainen, J(uha). |
| Harvima, I. |
| Hiltunen, M(ikko) |
| Jääskeläinen, J(uha) E. |
| Jäkälä, P(ekka) |
| Jänne, J. |
| Jantunen, E(sa) |
| Järvinen, R. |
| Julkunen, P. |
| Kaikkonen, M(inna) U. |
| Kauhanen, J(ussi) |
| Kivipelto, M(iia) |
| Koistinaho, M. |
| Koivisto, T(imo) |
| Kokki, H. |
| Könönen, M. |
| Kosma, V(eli)-M(atti) |
| Kröger, H. |
| Kurl, S(udhir) |
| Kuusisto, J(ohanna) |
| Laakso, M(arkku) |
| Lakka, T(imo) A. |
| Lapinlampi, N(iina) |
| Laukkanen, J(ari) (UEF/KSSHP) |
| Levonen, A(nna)-L(iisa) |
| Lindgren, A(ntti) E. |
| Löppönen, H(eikki) |
| Mannermaa, A. |
| Manninen, H. |
| Mecklin, J(ukka)-P(ekka) |
| Moilanen, L(eena) |
| Mönkkönen, J. |
| Mykkänen, H. |
| Nuutinen, J. |
| Paajanen, H. |
| Paananen, J. |
| Palvimo, J.J. |
| Pelkonen, J(ukka) |
| Pihlajamäki, J(ussi) |
| Pihlajamäki, M. |
| Pitkänen, A(sla) |
| Punnonen, K. |
| Raatikainen K |
| Rauramaa, R. |
| Rissanen, T.T. |
| Roine, R(isto) P. |
| Ryynänen, O.P. |
| Saarikoski, S. |
| Schwab, U(rsula) |
| Sivenius, J. |
| Soininen, H(ilkka) |
| Soininen, P(asi) |
| Sorri, I. |
| Stancakova, A(lena) |
| Sulkava, R. |
| Sund, R(eijo) |
| Tammi, M. |
| Tanila, H(eikki) |
| Tiihonen, J(ari) |
| Uusaro, A. |
| Uusitupa, M. |
| Vanninen, R. |
| Vaskilampi, T. |
| Viinamäki, H(eimo) |
| Virtanen, M(arianna) |
| Voutilainen, R(aimo) |
| Voutilainen, S(ari) |
| Wahlfors, J. |
| Wirth, T. |
| Wong, G. |
| Ylä-Herttuala, S(eppo) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis 1 | Harvima, I. | 21 days | save |  |  |  |  |
| Mast Cells and Sensory Nerves Contribute to Neurogenic Inflammation and Pruritus in Chronic Skin Inflammation | Harvima, I. | 92 days | save | | | | |
| Mast Cells Are a Marked Source for Complement C3 Products That Associate with Increased CD11b-Positive Cells in Keratinocyte Skin Carcinomas | Harvima, I. | 92 days | save | | | | |
| Mast cell chymase degrades fibrinogen and fibrin | Harvima, I. | 92 days | save | | | | |
| Increase in FoxP3-positive Cells and Their Contacts with Mast Cells in Köbner-negative Patients with Psoriasis after Tape-stripping | Harvima, I. | 92 days | save | | | | |
| Mast cell-neural interactions contribute to pain and itch | Harvima, I. | 92 days | save | | | | |
| Accuracy and reliability of a hand-held in vivo skin indentation device to assess skin elasticity | Harvima, I. | 92 days | save | | | | |
| Immunoreactivity to CYP24A1, but not vitamin D receptor, is increased in mast cells of keratinocyte skin cancers | Harvima, I. | 92 days | save | | | | |
| CD40 Ligand Is Increased in Mast Cells in Psoriasis and Actinic Keratosis but Less So in Epithelial Skin Carcinomas | Harvima, I. | 92 days | save | | | | |
| Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase | Harvima, I. | 92 days | save | | | | |
| Immediate Wheal Reactivity to Autologous Sweat in Atopic Dermatitis Is Associated with Clinical Severity, Serum Total and Specific IgE and Sweat Tryptase Activity | Harvima, I. | 92 days | save | | | | |
| Increased mitogen-stimulated lymphocyte proliferation is associated with the clinical response in major depressive disorder in women: A follow-up study | Harvima, I. | 92 days | save | | | | |
| Mast cell chymase in experimentally induced psoriasis | Harvima, I. | 92 days | save | | | | |
| Epidermal Expression of Filaggrin/Profilaggrin Is Decreased in Atopic Dermatitis: Reverse Association With Mast Cell Tryptase and IL-6 but Not With Clinical Severity | Harvima, I. | 92 days | save | | | | |
| Mast cell tryptase and chymase in the progress of cutaneous vasculitis | Harvima, I. | 92 days | save | | | | |
| Mast cells express CYP27A1 and CYP27B1 in epithelial skin cancers and psoriasis | Harvima, I. | 92 days | save | | | | |
| Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma | Harvima, I. | 92 days | save | | | | |
| Experimentally induced psoriatic lesions associate with rapid but transient decrease in interleukin-33 immunostaining in epidermis | Harvima, I. | 92 days | save | | | | |
| Increased numbers of tryptase-positive mast cells in the healthy and sun-protected skin of tobacco smokers | Harvima, I. | 92 days | save | | | | |
| Decrease in chymase activity is associated with increase in IL-6 expression in mast cells in atopic dermatitis | Harvima, I. | 92 days | save | | | | |
| Molecular targets on mast cells and basophils for novel therapies | Harvima, I. | 92 days | save | | | | |
| Reduced serum adiponectin levels in alexithymia | Harvima, I. | 92 days | save | | | | |
| Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor | Harvima, I. | 92 days | save | | | | |
| Glucocorticoids and aetiopathogenesis of depression | Harvima, I. | 92 days | save | | | | |
| Anti-apoptotic BFL-1 is the major effector in activation-induced human mast cell survival | Harvima, I. | 92 days | save | | | | |
| OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity | Harvima, I. | 92 days | save | | | | |
| Stress, the neuroendocrine system and mast cells: current understanding of their role in psoriasis | Harvima, I. | 92 days | save | | | | |
| Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder | Harvima, I. | 92 days | save | | | | |
| Mast cells as regulators of skin inflammation and immunity | Harvima, I. | 92 days | save | | | | |
| Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro | Harvima, I. | 92 days | save | | | | |
| The BH3-mimetic ABT-737 induces mast cell apoptosis in vitro and in vivo: potential for therapeutics | Harvima, I. | 92 days | save | | | | |
| Role of mast cells and sensory nerves in skin inflammation | Harvima, I. | 92 days | save | | | | |
| Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation | Harvima, I. | 92 days | save | | | | |
| Human mast cells adhere to and migrate on epithelial and vascular basement membrane laminins LM-332 and LM-511 via alpha3beta1 integrin | Harvima, I. | 92 days | save | | | | |
| Induction of matrix metalloproteinase-9 in keratinocytes by histamine | Harvima, I. | 92 days | save | | | | |
| Is there a role for mast cells in psoriasis? | Harvima, I. | 92 days | save | | | | |
| Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysis | Harvima, I. | 92 days | save | | | | |
| Expression of 15-lipoxygenase type-1 in human mast cells | Harvima, I. | 92 days | save | | | | |
| The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma | Harvima, I. | 92 days | save | | | | |
| Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency | Harvima, I. | 92 days | save | | | | |
| Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma | Harvima, I. | 92 days | save | | | | |
| Histamine, but not leukotriene C4, is an essential mediator in cold urticaria wheals | Harvima, I. | 92 days | save | | | | |
| Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion | Harvima, I. | 92 days | save | | | | |
| Hyaluronic acid inhibits the adherence and growth of monolayer keratinocytes but does not affect the growth of keratinocyte epithelium | Harvima, I. | 92 days | save | | | | |
| How should the care of dermatological diseases be developed? | Harvima, I. | 92 days | save | | | | |
| CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma | Harvima, I. | 92 days | save | | | | |
| Effect of temporin A modifications on its cytotoxicity and antimicrobial activity | Harvima, I. | 92 days | save | | | | |
| Efficacy of dietary hempseed oil in patients with atopic dermatitis | Harvima, I. | 92 days | save | | | | |
| Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors | Harvima, I. | 92 days | save | | | | |
| Study of innervation, sensory neuropeptides, and serotonin in murine contact allergic skin | Harvima, I. | 92 days | save | | | | |
| | 
report | next » | | |
|
